BUDESONIDE ALDO-UNION 0.5 mg/ml SUSPENSION FOR NEBULIZER INHALATION

2. What you need to know before taking Budesonide Aldo-Union

Do not use Budesonide Aldo-Union:

If you are allergic to budesonide or any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Budesonide Aldo-Union if any of the following situations apply to you:

• If you have or have had tuberculosis
• If you have or have had liver disease or problems.
• If you have a fungal, viral, or other infection of the airways, e.g., a cold or lung infection.

Contact your doctor if you experience blurred vision or other visual disturbances.

If you are switching from oral corticosteroid treatment (such as prednisolone) to Budesonide for inhalation by nebulizer, you may feel unwell during the change. You may also experience symptoms that were suppressed by the oral corticosteroids, such as allergic rhinitis (itching, nasal congestion, or runny nose), eczema (dry skin, itching), muscle pain, and joint pain. You should inform your doctor if this happens.

Budesonide, suspension for inhalation by nebulizer, is not suitable for use in acute asthma attacks. A sudden attack of shortness of breath should be treated with a short-acting bronchodilator.

If you experience more wheezing and/or difficulty breathing immediately after using Budesonide, suspension for inhalation by nebulizer, stop using it immediately and consult your doctor.

To reduce the risk of oral candidiasis (white patches on the tongue or in the mouth), rinse your mouth with water (spit out the water, do not swallow it) and brush your teeth after using Budesonide, suspension for inhalation by nebulizer. Inform your doctor if you develop oral candidiasis.

Children and adolescents

On rare occasions, long-term treatment with budesonide may delay normal growth in children and adolescents. If your child uses this medicine for a prolonged period, it is normal for your doctor to want to monitor their height periodically.

Budesonide is a steroid. You should be aware that, as a result of using this medicine, you may test positive in doping tests. If this concerns you, consult your doctor.

Using Budesonide Aldo-Union with other medicines:

Tell your doctor if you are taking any of the following medicines that may interact with this product:

• Medicines for the treatment of fungal infections, such as ketoconazole or itraconazole
• Medicines for the treatment of HIV called ritonavir or saquinavir
• The antibiotics erythromycin and clarithromycin
• Other medicines to help you breathe.
• Estrogens and steroid contraceptives.

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking a medicine. If you become pregnant while using this medicine, you should contact your doctor as soon as possible.

Driving and using machines

The influence of inhaled budesonide on the ability to drive and use machines is negligible.

3. How to use Budesonide Aldo-Union

Follow the instructions for administration of the medicine indicated by your doctor. In case of doubt, consult your doctor again.

Your doctor will indicate the correct dose depending on the severity of your asthma.

Asthma

You may notice that your asthma improves after 3 days, but it will take 2 to 4 weeks to achieve the full effect. It is essential that you continue taking the medicine as prescribed by your doctor, even if you feel better.

Adults (including the elderly) and adolescents 12 years and older:

The usual dose is 0.5 to 2 mg of budesonide per day. This dose will usually be divided into two doses, although if your asthma is stable and not severe, your doctor may advise you to take it once a day. Your doctor will advise you on how and when to take the medication, and you should always follow their instructions.

Children from 6 months to 11 years:

The usual dose is 0.25 to 1.0 mg of budesonide per day. Your doctor will advise you when your child should use the medicine, but it will usually be in two doses per day. However, if your child's asthma is stable and not severe, your doctor may advise you to give the medicine once a day.

Pseudocroup:

The usual dose in infants and children with pseudocroup is 2 mg. It can be administered in a single dose or in two doses of 1 mg, separated by a 30-minute interval. The administration can be repeated every 12 hours until improvement is observed, for a maximum of 36 hours.

Method of use

The medicine must be used with a nebulizer. The mist produced is inhaled through a mouthpiece or mask. Ultrasonic nebulizers should not be used with this medicine.

To take the medicine, follow these steps:

1. Gently shake the reservoir again and start the nebulization. During nebulization, breathe in the mist of the nebulized suspension deeply and slowly.
2. When no more mist comes out of the mouthpiece or mask, the treatment is finished.
3. When you have finished, rinse your mouth with water (do not swallow the water) and brush your teeth. If you have used a mask, wash your face well. It is essential to do this to reduce the risk of some side effects associated with this medicine.
   1. After each use, wash the nebulizer thoroughly. Wash the nebulizer reservoir and mouthpiece or mask with warm water using a mild detergent, following the manufacturer's instructions. The nebulizer should be rinsed well and dried by connecting the reservoir to the compressor or air outlet.

It is essential that you always follow the manufacturer's instructions that come with the nebulizer. If you are unsure about how to use the nebulizer, consult your doctor or pharmacist.

Your doctor may also prescribe the following:

• Your doctor may consider adding oral steroids to your treatment during critical periods (such as if you have an infection), before surgery, or if you have been taking a high dose of an inhaled steroid for a prolonged period.
• If you have been taking oral steroids for your asthma, your doctor will reduce the amount you need to take once you start using Budesonide suspension for inhalation by nebulizer. Due to this, you may notice some symptoms such as a stuffy nose or runny nose, lack of energy, depression, eczema, and muscle or joint pain. If any of these symptoms persist and are very bothersome, you should consult your doctor.
• Your doctor may advise you to mix this medicine with other suspensions that contain other active substances that act on the respiratory system, such as salbutamol, terbutaline, sodium cromoglycate, and ipratropium bromide. If so, follow their instructions carefully. Do not mix this medicine unless your doctor has specifically instructed you to do so.

If you have used more Budesonide Aldo-Union than you should

Contact your doctor or pharmacist as soon as possible. Remember to take the package and any remaining blisters with you. It is essential that you take the dose indicated on the label by the pharmacist or the dose recommended by your doctor. You should not increase or decrease the dose without medical consent.

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service immediately. Phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to use Budesonide Aldo-Union

Do not take a double dose to make up for forgotten doses. Simply take the next dose at the scheduled time.

If you have any doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

All medicines can cause allergic reactions, although severe allergic reactions are very rare. Inform your doctor immediately if you suddenly experience wheezing, difficulty breathing, swelling of the eyelids, face, or lips, rash, or itching (especially if it affects the whole body).

Rarely, inhaled medicines like budesonide can cause acute wheezing and/or difficulty breathing. If this happens, stop using the medicine immediately and consult your doctor.

The following side effects have been reported:

Common:may affect up to 1 in 10 people: Muscle pain and/or irritation of the mouth (including oral thrush or mouth ulcers), hoarseness, throat irritation, difficulty swallowing, and cough.

Uncommon:may affect less than 1 in 100 people

Cataracts (opacity of the eye lens), depression or feeling anxious, muscle spasms, tremors, blurred vision.

Rare:may affect up to 1 in 1,000 people: Skin reactions, including itching, rash, bruising, swelling, redness, and/or skin eruptions, hives, growth delay in children and adolescents, hypersensitivity (an allergy to the medicine), and bronchospasm (contraction of the airway muscles that causes wheezing). Voice problems.

Suppression of the adrenal gland (a small gland near the kidney) may occur. The main symptoms of adrenal suppression include headache, fatigue, nausea, vomiting, weight loss, stomach pain, and loss of appetite.

Feeling restless, nervous, overexcited, or irritable (these effects are more likely to occur in children)

Very rare:may affect up to 1 in 10,000 people: Decreased bone density (thinning of the bones).

Frequency not known:cannot be estimated from the available data

Glaucoma (increased pressure inside the eye), aggression, increased motor activity (difficulty staying still), sleep disorders.

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's online platform: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Budesonide Aldo-Union

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton or pouch after EXP. The expiry date is the last day of the month indicated.

Store the blisters in their aluminum pouch and in their original packaging to protect them from light and moisture.

Once a blister is opened, it must be used within 12 hours. After this time, any unused amount must be discarded.

Once a pouch is opened, the blisters can be stored for up to 3 months (it is recommended to note the opening date on the pouch to help you remember it)

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the SIGRE collection point at your usual pharmacy or any other medication waste collection system. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and further information

Composition of Budesonide Aldo-Union

• The active ingredient is Budesonide
• The other ingredients are disodium edetate, sodium chloride, polysorbate 80, citric acid, sodium citrate, and purified water.

Budesonide Aldo-Union 0.5 mg/ml, suspension for inhalation by nebulizer, contains 1.0 mg of budesonide (0.5 mg/ml) as the active ingredient in each 2 ml blister.

Appearance of Budesonide Aldo-Union and pack contents

Budesonide Aldo-Union is presented in plastic blisters with 2 ml of white or off-white suspension to be nebulized (converted into a fine mist for inhalation).

The blisters are packaged in strips of 4, 5, 8, 10, or 12 blisters in an aluminum pouch, which is then packaged in a cardboard box. There are packs containing 5, 20, 24, 40 (2 x 20), or 60 blisters. Not all pack sizes may be marketed.

Marketing Authorization Holder:

Laboratorio Aldo-Unión, S.L. c/ Baronesa de Malda nº 73, Esplugues de Llobregat, 08950 Barcelona (Spain)

Manufacturer:

UNITHER PHARMACEUTICALS 151 Rue Andre Durouchez, Espace Industriel Nord Amiens Cedex 2. 80084 France

This medicine is authorized in the EEA Member States under the following names:

Denmark Budesonid Arrow

Belgium Budesonide Sandoz 0.5 mg/ml vernevelsuspensie

Germany BUDENOBRONCH 1.0mg/2ml Suspension für einen Vernebler

Spain Budesonida Aldo-Unión 0.5mg/ml suspensión para inhalación por nebulizador

Italy Budesonide Sandoz 0.5mg/ml sospensione per nebulizzatore

Luxembourg Budesonid „Arrow“ 0.5mg/ml Suspension für einen Vernebler

Netherlands Budesonide Sandoz 0.5mg/ml vernevelsuspensie in ampul, 2ml.

Norway Budesonid Arrow inhalasjonsvæske til nebulisator, suspensjon 0.5mg/ml

Sweden Budesonid Arrow 0.5mg/ml suspension för nebulisator

United Kingdom Budesonide 1mg Nebuliser Suspension

Date of last revision of this package leaflet:May 2016

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/